Rohto Pharmaceutical Co.,Ltd. (TYO:4527)
Japan flag Japan · Delayed Price · Currency is JPY
2,866.50
-0.50 (-0.02%)
Aug 21, 2026, 3:30 PM JST

Rohto Pharmaceutical Stock Forecast

Stock Price Forecast

According to 11 analysts polled by S&P Global, Rohto Pharmaceutical stock has a consensus rating of "Buy" and an average price target of ¥2,975. The average 1-year stock price forecast is 3.80% higher than the current stock price, while the lowest is ¥2,300 (-19.76%) and the highest is ¥3,300 (+15.12%).

Price Target: ¥2,975 (+3.80%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price¥2,300¥2,975¥3,050¥3,300
Change-19.76%+3.80%+6.40%+15.12%
* Price targets were last updated on Jul 14, 2026.

Analyst Ratings

The average analyst rating for Rohto Pharmaceutical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingMar '26Apr '26May '26Jun '26Jul '26Aug '26
Strong Buy344444
Buy333444
Hold444333
Sell000000
Strong Sell000000
Total101111111111

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Jefferies
Jefferies
Buy
Maintains
¥2,950
BuyMaintains¥2,950+2.91%Jul 14, 2026

Financial Forecast

Revenue This Year
371.06B
from 343.73B
Increased by 7.95%
Revenue Next Year
385.33B
from 371.06B
Increased by 3.85%
EPS This Year
n/a
EPS Next Year
n/a
Fiscal YearFY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingMar 31, 2022Mar 31, 2023Mar 31, 2024Mar 31, 2025Mar 31, 2026Mar 31, 2027
Revenue
199.65B238.66B270.84B308.63B343.73B371.06B
Revenue Growth
10.13%19.54%13.48%13.95%11.37%7.95%
Gross Profit
116.49B137.42B157.29B174.94B192.70B209.28B
Gross Margin
58.35%57.58%58.07%56.68%56.06%56.40%
Operating Income
28.19B33.54B40.17B38.47B40.71B45.04B
Net Income
21.02B26.38B30.94B31.01B34.25B35.02B
Dividend / Share
18.0022.0027.0036.0046.0050.02
Dividend Growth
28.57%22.22%22.73%33.33%27.78%8.74%
Free Cash Flow
11.70B12.45B15.30B16.65B9.06B26.25B
No. Analysts
-----8
Financial currency is JPY.

Revenue Forecast

Revenue202720282029
High373.1B
Avg371.1B
Low366.5B

Revenue Growth

Revenue Growth202720282029
High
8.5%
Avg
8.0%
Low
6.6%

EPS Forecast

EPS202720282029
High-
Avg-
Low-

EPS Growth

EPS Growth20282029
High-
Avg-
Low-